Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-22

FDA Approved: FOSAMPRENAVIR CALCIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fosamprenavir calcium from Sun Pharmaceutical Industries, Inc., updating the approval under the ANDA for this antire…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosamprenavir calcium (fosamprenavir calcium)

Snippet

SUPPL AP for FOSAMPRENAVIR CALCIUM (FOSAMPRENAVIR CALCIUM)